Genistein suppresses doxorubicin associated genotoxicity in human lymphocytes
Doxorubicin is a well-known DNA intercalating chemotherapy drug that is widely used for treatment of different cancers. Its clinical utility is limited due to the observed genotoxic side effects on healthy cells suggesting that newer combination and genoprotective regimens are urgently needed for th...
Guardado en:
Autores principales: | Beg, Tanveer, Siddique, Yasir H., Ara, Gulshan, Afzal, Mohammad, Azmi, Asfar S. |
---|---|
Formato: | Articulo |
Lenguaje: | Inglés |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/8300 http://www.latamjpharm.org/resumenes/30/7/LAJOP_30_7_1_10.pdf |
Aporte de: |
Ejemplares similares
-
Preparation, crystal structure and prodrug studies of genistein benzensulfonate
por: Peng, You, et al.
Publicado: (2011) -
Oral bioavailability of novel genistein sulfonates and their pre-clinical pharmacokinetics
por: Fan, Yaw-ei, et al.
Publicado: (2011) -
Isoflavonas en Soja y Productos Derivados: Contenido de Daidzeina y Genisteina
por: Ludueña, Beatriz Del Valle
Publicado: (2008) -
Lovastatin enhances the antitumoral and apoptotic activity of doxorubicin in murine tumor models
por: Rozados, Viviana R., et al.
Publicado: (2012) -
Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas
por: Mainetti, Leandro Ernesto, et al.
Publicado: (2018)